Monocytes from patients with chronic myelomonocytic leukemia (CMML-Mo) strongly expressed CD14 and CD2, but not CD16. Macrophages (M) generated from CMML-Mo expressed CD32, but not CD16. The expression levels of CD64 were significantly reduced from normal M. While CMML-Mo-derived M phagocytosed sensitized SRBC, these cells exhibited a similar defect as CMML-Mo in the ability to produce O2 − . CMML-Mo could generate dendritic cells (DC), but not multinucleated giant cells (MGC), suggesting that CMML-Mo are different from normal Mo in cell surface marker expression, O2 − production, and the ability to differentiate into M and MGC, but not DC.
INTRODUCTION
Normal monocytes (Mo) can differentiate into macrophages (M), osteoclast-like multinucleated giant cells (MGC), and dendritic cells (DC) in differing cytokine environments of macrophage colony-stimulating factor (M-CSF) alone, M-CSF and interleukin 4 (IL-4), and granulocytemacrophage colony-stimulating factor (GM-CSF) and IL-4, respectively 1 . Chronic myelomonocytic leukemia (CMML) is a myeloproliferative disorder exhibiting peripheral blood monocytosis. Although CMML-Mo are known to be able to differentiate into DC 2 , there is no report examining if CMMLMo can differentiate into M or MGC. In this study, we investigate the ability of CMML-Mo to differentiate into M and MGC following treatment with M-CSF and M-CSF+IL-4, respectively.
MATERIALS AND METHODS
Patients : CMML samples were obtained from four patients, whose clinical characteristics are detailed in Table 1 . All samples were acquired after obtaining informed consent with the approval of the local ethics committee.
Preparation and culture of Mo : Mo were isolated from PBMCs obtained from CMML patients using a magnetic cell separation system (MACS ; Miltenyi Biotec, Bergisch Gladbach, Germany) with anti-CD14 mAb-coated microbeads as described 3 . CD14 + Mo were cultured for seven days at a density of 5 × 10 5 /2 ml in RPMI1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS) in the 6-well plates (Falcon ; Becton, Dickinson and Company, Franklin Lakes, NJ) at 37℃ in an atmosphere of 5% CO2 in air. Cultures were treated with M-CSF, GM-CSF+IL-4 or M-CSF+IL-4 at the following concentrations : 500 U/ml GM-CSF (Schering-Plough Japan, Osaka, Japan), 1 × 10 4 U/ml M-CSF (Morinaga Milk Industry Co., Ltd., Tokyo, Japan), and 100 U/ml IL-4 (GENZYME TECHNE, Minneapolis, MN).
Phenotypic analysis : Expression of cell surface markers was assessed using fluorescein (FITC)-and phycoerythrin (PE)-conjugated mouse mAbs specific for CD2, CD13, CD14, CD16, CD33, HLA-DR (BD, San Jose, CA), CD32, CD64 (BD Pharmingen, San Diego, CA), and CD1a (Beckman Coulter, Inc., Florida, MA), as well as isotype control mouse MoAbs (BD). To block nonspecific Fc-receptor-mediated binding of mAbs, cells were pre-incubated for 30 min at 0℃ in normal goat serum (Cedarlane Laboratories Ltd., Hornby, Ontario, Canada) before staining. Stained cells were analyzed using a FACS Calibur cytometer (BD) equipped with Cell Quest software (BD).
Phagocytosis of M : M derived from CMML-Mo in RPMI1640/10% FCS were incubated at 37℃ with 0.2% latex particles (average diameter 1 mm, Dow Chemical Co., Indianapolis, IN, USA) for 4 hrs or with 0.4% sensitized sheep red blood cells (EA) for 1 hr, then washed three times in PBS without Ca ++ or Mg ++ . Superoxide generation assay : To measure the amount of superoxide anion (O2 − ) generated by cells stimulated with phorbol myristate acetate (PMA, 100 ng/ml), we used lucigenin-dependent SOD-inhibitable chemiluminescence 4 . The chemiluminescence response, measured every 10 min using a Berthold LB96P luminometer, was expressed as relative light units (RLU).
RESULTS AND DISCUSSION
Almost all the Mo obtained from four CMML patients expressed CD14, as well as HLA-DR, CD13, and CD33, as demonstrated by previous studies 2 . The majority of the Mo derived from the four CMML patients, as well as normal-Mo, expressed CD32 and CD64 (Table 1) . Consistent previous studies 5, 6 , approximately 22% (10-30%) and 31% (16-39%) of normal-Mo expressed CD16 and CD2, respectively. In contrast, CMML-Mo did not express significant levels of CD16 (0-3%), while increased cell numbers strongly expressed CD2 (59-99%) ( Table 1 (Fig. 2) . CMML-M exhibited normal phagocytosis of latex particles and the Fcreceptor-mediated internalization of EA (Table 1) . As seen for normal M, the majority of CMML-M expressed CD32 ; surface expression of CD64 by CMML-M, however, was lower than that seen by normal M (Table 1, Fig. 3 ). CMML-M did not express significant levels of CD16, which is expressed strongly by normal-M 7, 8 (Table 1, Fig.  3) . Previous studies have shown that the expression of CD16 by Mo and M is enhanced by IL-10 7 ; IL-10 is produced by Mo cultured in M-CSF 9 . Thus, the possibility exists that CMML-Mo are defective in IL-10 production following M-CSF stimulation. We do not currently understand, however, the mechanisms underlying the lack of CD16 expression by CMML-Mo and CMML-M.
The production of reactive oxygen intermediates, such as O2 − , by Mo/M plays a fundamental role in innate immune responses. These substances possess the ability to kill microbial pathogens within phagolysosomes. We therefore ex- amined the O2 − production by CMML-Mo and CMML-M. In contrast to normal-Mo and normal-M, neither CMMLMo nor CMML-M produced significant levels of O2 − following PMA stimulation (Fig. 4) . O2 − is produced by the activation of NADPH oxidase, an enzyme consisting of six subunits ; the integral membrane proteins p22 phox and gp91 phox , which form a heterodimeric flavocytochrome, bind four cytosolic proteins, the small GTPase Rac, p40 phox , p47 phox , and p67 phox 10 . Preliminary western blot analysis demonstrated that the protein levels of p47 and p67 in CMMLMo were similar to those seen in normal-Mo (data not shown), suggesting either impairment of the remaining components of NADPH oxidase or aberrant activation of the oxidase signaling pathway in CMML-Mo/ M. CMML-Mo cultured in GM-CSF and IL-4 differentiated into CD1a + DC, as reported 2 (Fig. 2) . Culture of CMML-Mo in M-CSF and IL-4, however, did not generate MGC (Fig. 2) . These results suggest that the signaling pathway induced by the combination of M-CSF+IL-4, but not that activated by GM-CSF+IL-4, is impaired in CMML-Mo. The precise mechanisms governing the inability of CMML-Mo to generate MGC following M-CSF+IL-4 treatment remains unclear.
In conclusion, CMML-Mo can differentiate into M following M-CSF treatment ; the M generated, however, are distinct from normal Mo-derived M in their expression of CD16 and capacity for O2 − production. Although CMMLMo are defective in their ability to differentiate into MGC following M-CSF+IL-4 treatment, these cells can differentiate into DC when given GM-CSF+IL-4. It will be interesting to use CMML-Mo to elucidate the signaling pathways involved in the differentiation of Mo into M and/or MGC that require M-CSF and/or M-CSF+IL-4. 
